Glycosylated Hemoglobin and Albumin-Corrected Fructosamine Are Good Indicators for Glycemic Control in Peritoneal Dialysis Patients

PLoS ONE

Volumn 8, Issue 3, 2013, Pages

  Lee, Szu Ying ^a   Chen, Yin Cheng ^b   Tsai, I Chieh ^b   Yen, Chung Jen ^a   Chueh, Shu Neng ^a   Chuang, Hsueh Fang ^a   Wu, Hon Yen ^a,c   Chiang, Chih Kang ^a   Cheng, Hui Teng ^a   Hung, Kuan Yu ^a   Huang, Jenq Wen ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b Taipei Hospital   (Taiwan)

^c FAR EASTERN MEMORIAL HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; FRUCTOSAMINE; GLUCOSE; GLYCOSYLATED ALBUMIN; HEMOGLOBIN A1C; ICODEXTRIN; INSULIN;

ACCURACY; ADULT; ARTICLE; BLOOD GLUCOSE MONITORING; CLINICAL ARTICLE; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; DIABETES MELLITUS; DIALYSATE; DIET THERAPY; FEMALE; GLYCEMIC CONTROL; HUMAN; MALE; PERITONEAL DIALYSIS; TISSUE PRESSURE;

AGED; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; DIALYSIS SOLUTIONS; EXTRACELLULAR FLUID; FEMALE; FRUCTOSAMINE; GLUCANS; GLUCOSE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; MONITORING, PHYSIOLOGIC; PERITONEAL DIALYSIS, CONTINUOUS AMBULATORY; SERUM ALBUMIN;

EID: 84874630657     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0057762     Document Type: Article

References (31)

1. Wu HY, Hung KY, Huang TM, Hu FC, Peng YS, et al. (2012) Safety issues of long-term glucose load in patients on peritoneal dialysis-a 7-year cohort study. PLoS One 7: e30337.
2. Wu HY, Hung KY, Huang JW, Chen YM, Tsai TJ, et al. (2008) Initial glucose load predicts technique survival in patients on chronic peritoneal dialysis. Am J Nephrol 28: 765-771.
3. Wu HY, Hung KY, Hu FC, Chen YM, Chu TS, et al. (2010) Risk factors for high dialysate glucose use in PD patients-a retrospective 5-year cohort study. Perit Dial Int 30: 448-455.
4. Ly J, Marticorena R, Donnelly S, (2004) Red blood cell survival in chronic renal failure. Am J Kidney Dis 44: 715-719.
5. Goldstein DE, Little RR, Lorenz RA, Malone JI, Nathan D, et al. (1995) Tests of glycemia in diabetes. Diabetes Care 18: 896-909.
6. Panzer S, Kronik G, Lechner K, Bettelheim P, Neumann E, et al. (1982) Glycosylated hemoglobins (GHb): an index of red cell survival. Blood 59: 1348-1350.
7. Smith WG, Holden M, Benton M, Brown CB, (1989) Glycosylated and carbamylated haemoglobin in uraemia. Nephrol Dial Transplant 4: 96-100.
8. Tzamaloukas AH, (1996) Interpreting glycosylated hemoglobin in diabetic patients on peritoneal dialysis. Adv Perit Dial 12: 171-175.
9. Joy MS, Cefalu WT, Hogan SL, Nachman PH, (2002) Long-term glycemic control measurements in diabetic patients receiving hemodialysis. Am J Kidney Dis 39: 297-307.
10. Nakao T, Matsumoto H, Okada T, Han M, Hidaka H, et al. (1998) Influence of erythropoietin treatment on hemoglobin A1c levels in patients with chronic renal failure on hemodialysis. Intern Med 37: 826-830.
11. Coronel F, Macia M, Cidoncha A, Sanchez A, Tornero F, et al. (1991) Fructosamine levels in CAPD: its value as glycemic index. Adv Perit Dial 7: 253-256.
12. Mittman N, Desiraju B, Fazil I, Kapupara H, Chattopadhyay J,et al. (2010) Serum fructosamine versus glycosylated hemoglobin as an index of glycemic control, hospitalization, and infection in diabetic hemodialysis patients. Kidney Int Suppl: S41-45.
13. Freedman BI, Shenoy RN, Planer JA, Clay KD, Shihabi ZK, et al. (2010) Comparison of glycated albumin and hemoglobin A1c concentrations in diabetic subjects on peritoneal and hemodialysis. Perit Dial Int 30: 72-79.
14. Peacock TP, Shihabi ZK, Bleyer AJ, Dolbare EL, Byers JR, et al. (2008) Comparison of glycated albumin and hemoglobin A(1c) levels in diabetic subjects on hemodialysis. Kidney Int 73: 1062-1068.
15. Gross TM, Bode BW, Einhorn D, Kayne DM, Reed JH, et al. (2000) Performance evaluation of the MiniMed continuous glucose monitoring system during patient home use. Diabetes Technol Ther 2: 49-56.
16. McGahan L (2002) Continuous glucose monitoring in the management of diabetes mellitus. Issues Emerg Health Technol: 1-4.
17. Riveline JP, Teynie J, Belmouaz S, Franc S, Dardari D, et al. (2009) Glycaemic control in type 2 diabetic patients on chronic haemodialysis: use of a continuous glucose monitoring system. Nephrol Dial Transplant 24: 2866-2871.
18. Marshall J, Jennings P, Scott A, Fluck RJ, McIntyre CW, (2003) Glycemic control in diabetic CAPD patients assessed by continuous glucose monitoring system (CGMS). Kidney Int 64: 1480-1486.
19. Executive summary: Standards of medical care in diabetes-2010. Diabetes Care 33Suppl 1: S4-10.
20. Hung KY, Huang JW, Tsai TJ, Chen WY, (2000) Natural changes in peritoneal equilibration test results in continuous ambulatory peritoneal dialysis patients: a retrospective, seven year cohort survey. Artif Organs 24: 261-264.
21. Bock HA, Hirt-Minkowski P, Brunisholz M, Keusch G, Rey S, et al. (2008) Darbepoetin alpha in lower-than-equimolar doses maintains haemoglobin levels in stable haemodialysis patients converting from epoetin alpha/beta. Nephrol Dial Transplant 23: 301-308.
22. Sulowicz W, Locatelli F, Ryckelynck JP, Balla J, Csiky B, et al. (2007) Once-monthly subcutaneous C.E.R.A. maintains stable hemoglobin control in patients with chronic kidney disease on dialysis and converted directly from epoetin one to three times weekly. Clin J Am Soc Nephrol 2: 637-646.
23. Reach G, (2008) Continuous glucose monitoring and diabetes health outcomes: a critical appraisal. Diabetes Technol Ther 10: 69-80.
24. Reach G, Choleau C, (2008) Continuous glucose monitoring: physiological and technological challenges. Curr Diabetes Rev 4: 175-180.
25. Weykamp CW, Miedema K, de Haan T, Doelman CJ, (1999) Carbamylated hemoglobin interference in glycohemoglobin assays. Clin Chem 45: 438-440.
26. Wong TY, Liew G, Tapp R, Schmidt MI, Wang JJ, et al. (2008) Relation between fasting glucose and retinopathy for diagnosis of diabetes: three population-based cross-sectional studies (vol 371, pg 736, 2008). Lancet 371: 1838-1838.
27. Gillett MJ, (2009) International Expert Committee report on the role of the A1c assay in the diagnosis of diabetes: Diabetes Care 2009; 32(7): 1327-1334. Clin Biochem Rev 30: 197-200.
28. Inaba M, Okuno S, Kumeda Y, Yamada S, Imanishi Y, et al. (2007) Glycated albumin is a better glycemic indicator than glycated hemoglobin values in hemodialysis patients with diabetes: Effect of anemia and erythropoietin injection. Journal of the American Society of Nephrology 18: 896-903.
29. Blumenkrantz MJ, Gahl GM, Kopple JD, Kamdar AV, Jones MR, et al. (1981) Protein losses during peritoneal dialysis. Kidney Int 19: 593-602.
30. Paniagua R, Ventura MD, Avila-Diaz M, Cisneros A, Vicente-Martinez M, et al. (2009) Icodextrin improves metabolic and fluid management in high and high-average transport diabetic patients. Perit Dial Int 29: 422-432.
31. Babazono T, Nakamoto H, Kasai K, Kuriyama S, Sugimoto T, et al. (2007) Effects of icodextrin on glycemic and lipid profiles in diabetic patients undergoing peritoneal dialysis. Am J Nephrol 27: 409-415.